Stock to Track: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)

July 18, 2016 1:11 PM

18
0

The Company fell -16.01% and finished at $2.99. The daily volume was measured at 3.57 million shares. The 52-week high of the share price is $3.87 and the 52-week low is $1.9. The company has a market cap of $66.41 million. Its latest closing price has a distance of 19.38% from SMA20 and is 25.53 up than SMA50. BCLI is currently showing ROA (Return on Assets) value of -46.2% where ROE (Return on Equity) is -53.6%.

Return on equity (ROE) measures the rate of return on the ownership interest (shareholders’ equity) of the common stock owners. It measures a firm’s efficiency at generating profits from every unit of shareholders’ equity (also known as net assets or assets minus liabilities).